Press Releases on November 9, 2023 - EIN Presswire - Press Release Distribution Service

Published on November 9, 2023 - 21:01 GMT

South Orange Township, NJ Expands GovPilot Partnership With New Government Management Software In 2023

The NJ Township expands their partnership with the government management software provider to streamline operations and government services in the municipality. SOUTH ORANGE , NJ, UNITED STATES, November 9, 2023 /⁨EINPresswire.com⁩/ -- Customer Since 2014 …

Distribution channels: IT Industry, Politics ...

Published on November 9, 2023 - 21:02 GMT

TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:02 GMT

Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

FDA clearance of IND for NKX019 in lupus nephritis expands pipeline into autoimmune disease NKX019, a first-in-class engineered NK cell therapy, has disease-modifying potential in autoimmune disease while maintaining NK-driven safety profile New pipeline …

Distribution channels:

Published on November 9, 2023 - 21:02 GMT

BLINK CHARGING ANNOUNCES RECORD THIRD QUARTER WITH 152% REVENUE GROWTH TO $43.4 MILLION AND 167% INCREASE IN GROSS PROFIT

Company raises 2023 revenue target to $128 - $133 million and targets adjusted EBITDA break even run rate by December 2024 Third quarter 2023 total revenues increased 152% to $43.4 million compared to $17.2 million in third quarter of 2022 167% increase in …

Distribution channels: Automotive Industry ...

Published on November 9, 2023 - 21:01 GMT

10 November 2023: The Week in Australian Foreign Affairs

This week in Australian foreign affairs: Albanese’s official visit to China; Pacific Islands Forum Leaders’ Meeting; Wong in Japan; and more. From 4 to 7 November, Prime Minister Anthony Albanese undertook an official visit to China on the invitation of Li …

Distribution channels: Politics

Published on November 9, 2023 - 21:01 GMT

Applied Molecular Transport Reports Third Quarter 2023 Financial Results

Company Entered into Definitive Merger Agreement with Cyclo Therapeutics Cash and Cash Equivalents of $18.1 million, as of September 30, 2023 SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:01 GMT

Plug Power Announces 2023 Third Quarter Results

LATHAM, N.Y., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has announced its 2023 third quarter results. The quarterly shareholder letter has been …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 9, 2023 - 21:01 GMT

Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Progress

Ventyx to provide updates across clinical-stage portfolio in the first quarter of 2024 Cash, cash equivalents and marketable securities of $300.8 million as of September 30, 2023 SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:01 GMT

Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on the Company’s key developments and business operations. “ …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Barinthus Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

OXFORD, United Kingdom, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced its financial results for the third quarter of 2023 and provided an overview of its progress. The Company is a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 9, 2023 - 21:01 GMT

Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

The first patient was dosed in our Phase 1/2 study for ONCT-534, our dual-action androgen receptor inhibitor, for the treatment of patients with advanced prostate cancer who are resistant to approved androgen receptor pathway inhibitors Additional patients …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference

Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to date All three patients receiving multiple Mylotarg™ doses exhibited hematologic protection, further validating Vor Bio’s approach Conference call today, November 9 at 4: …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on November 9, 2023 - 21:01 GMT

AirSculpt Technologies Announces Third Quarter 2023 Results and Reaffirms 2023 Guidance

MIAMI BEACH, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2023 …

Distribution channels: Business & Economy, Consumer Goods ...

Published on November 9, 2023 - 21:01 GMT

Humacyte Third Quarter 2023 Financial Results and Business Update

– Positive top line results from the V005 Phase 2/3 trial of the Human Acellular Vessel™ (HAV™) in vascular trauma repair – – BLA for an indication in vascular trauma planned to be filed with the FDA during the current quarter – - Conference call and live …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

October 2023 financing funds late-stage clinical trials of HPN328 in multiple tumor types Positive interim results from Phase 1/2 trial of T cell engager HPN328 in patients with small cell lung cancer (SCLC) and other neuroendocrine tumor types presented …

Distribution channels: Business & Economy, Technology ...

Published on November 9, 2023 - 21:01 GMT

Erasca Reports Third Quarter 2023 Financial Results and Business Updates

First patient dosed in SEACRAFT-1 Phase 1b trial evaluating naporafenib plus trametinib Multiple upcoming catalysts across ongoing clinical programs Strong balance sheet with cash, cash equivalents, and marketable securities of $344 million as of September …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Teknova Reports Third Quarter 2023 Financial Results

Raised $22.9 million of equity capital, paid down $10.0 million of long-term debt Third quarter 2023 total revenue was $8.2 million, down 24% from prior year Expect 2023 revenue at the low end of previously announced guidance range of $37-40 million …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Enrollment completed in CANOPY Phase 3 pivotal clinical trial investigating VYD222 for the prevention of symptomatic COVID-19 Company expects to have initial CANOPY primary endpoint data by late 2023 or early Q1 2024 Company aims to submit an application …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

CompoSecure Reports Third Quarter 2023 Financial Results

SOMERSET, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its financial and operating results for the third quarter ended September 30, 2023. …

Distribution channels:

Published on November 9, 2023 - 21:01 GMT

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

Product sales and royalty revenue of $7.0 million up 118% from Q3 2022, representing the eleventh straight quarter of sequential product sales and royalty revenue growth Generated $0.9 million in positive cash flow from operations; ended quarter with $22.1 …

Distribution channels: